Valuation
P/E Ratio -0,79x
P/B Ratio 0,52x
P/S Ratio 0,22x
P/FCF Ratio -1,27x
Margins
Gross Margin 11,03 %
Operating Margin -17,81 %
Net Margin -23,10 %
ELIXINOL GLOBAL Share · AU000000EXL4 · A2JB8D (XASX) Australia · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ELIXINOL GLOBAL
No Price
04.09.2026 17:56
Company Profile for ELIXINOL GLOBAL Share
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
Company Data
Name ELIXINOL GLOBAL
Company Elixinol Wellness Limited
Website
https://www.elixinolwellness.com
Primary Exchange 
ASX
ASX
WKN A2JB8D
ISIN AU000000EXL4
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Natalie Butler
Country Australia
Currency EUR
Employees -
Address 680 George Street, 2000 Sydney
IPO Date 2018-06-05
Key Ratios
As of 07.09.2026
Stock Splits
| Date | Split |
|---|---|
| 02.12.2024 | 1:8 |
| 06.05.2020 | 579:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ELLXF |
| Frankfurt | E8M.F |